India-Produced Meningitis Vaccine Said To Be Viable In Hot Climates
This article was originally published in PharmAsia News
Executive Summary
India's own MenAfriVac vaccine against meningitis has been backed by the World Health Organization as a drug that remains stable when exposed to high temperatures for up to four days.